GULAI, GOLIKOV
614
Scheme 2.
Ph
O
O
Ph
O
Ph
O
N
N
N
Path a
OEt
OEt
NH
OH
HN
OEt
( )n
( )n
( )n
+
N
–H2O
H2N
N
N
N
H
N
HO
HO
HO
N
N
Ph
Ph
Ph
H
Ph
Ph
Ph
OH
EtO
EtO
O–
N
OH
N
N
( )n
( )n
( )n
N
N
–EtOH
–H2O
N
N
N
N
N
N
H
HO
HO
Ph
Ph
Ph
IIIa, IVa
N
Ph
O
Ph
OEt HN
N
N
N
Path b
OEt
N
( )n
( )n
OH H
+
H2N
N
O
O
H
HO
Ph
HO
Ph
Ph
OH
N
Ph
OH
Ph
OH
N
N
N
N
( )n
( )n
( )n
–EtOH
–2H2O
H
N
N
N
N
O–
OH
HO
HO
Ph
Ph
Ph
N
N
N
IIIb, IVb
the product mixtures. The spectra contained, respec-
tively, four and five signals from sp3-carbon atoms,
which indicated that the heterocyclization was accom-
panied by dehydration.
and 0.22 g (2.6 mmol) of 3-amino-1,2,4-triazole was
heated for 60 min at 140–160°C. The crystalline prod-
uct was washed with water and ethanol. Overall yield
0.67 g (66%), light-yellow crystals, mp 242–260°C
1
(decomp.). H NMR spectrum, δ, ppm: 4.68 s and
A probable scheme of formation of isomeric line-
arly and angularly fused triazoloquinazoline deriva-
tives involves initial nucleophilic attack by the primary
amino group of aminotriazole at the ketone (path a) or
ester carbonyl group (path b) in the substrate. The sub-
sequent attack by the pyridine-type nitrogen atom in
the triazole fragment on the other carbonyl carbon
atom leads to the corresponding intramolecular cy-
clization products (Scheme 2).
4.62 s (1H, 6-H), 5.79 br.s (5-OH), 6.18 s and 6.35 s
(1H, 9-CH), 7.14–7.42 m (10H, Harom), 8.14 s and
8.16 s (1H, 3-H). 13C NMR spectrum, δC, ppm: 26.82
(C7), 29.90 (C8), 32.05 (C10), 43.21 (C6), 152.48 (C3).
Found, %: C 76.01; H 5.44; N 14.48. C25H20N4O.
Calculated, %: C 76.51; H 5.14; N 14.28.
10-Benzylidene-6-phenyl-6,7,8,9,10,11-hexahy-
drobenzo[g][1,2,4]triazolo[3,4-b]quinazolin-5-ol
(IVa) and 10-benzylidene-6-phenyl-6,7,8,9,10,11-
hexahydrobenzo[g][1,2,4]triazolo[4,3-a]quinazolin-
5-ol (IVb) were synthesized in a similar way. Yield
63%, mp 227–237°C (decomp.). 1H NMR spectrum, δ,
ppm: 4.47 s and 4.41 s (1H, 6-H), 5.65 br.s (5-OH),
6.48 s and 6.62 s (10-CH), 7.13–7.34 m (10H, Harom),
8.09 s and 8.11 s (1H, 1-H). 13C NMR spectrum, δC,
ppm: 22.76 (C8), 27.29 (C7), 29.11 (C9), 29.23 (C11),
46.67 (C6), 152.24 (C3). Found, %: C 76.53; H 5.75;
N 13.92. C26H22N4O. Calculated, %: C 76.83; H 5.46;
N 13.78.
Heterocyclic systems III and IV consist of four
fused rings, and they can be regarded as structural
analogs of tetracycline antibiotics. Therefore, we plan
to separate the obtained mixtures of isomers with
a view to examine their biological activity.
9-Benzylidene-6-phenyl-7,8,9,10-tetrahydro-6H-
cyclopenta[g][1,2,4]triazolo[3,4-b]quinazolin-5-ol
(IIIa) and 9-benzylidene-6-phenyl-7,8,9,10-tetra-
hydro-6H-cyclopenta[g][1,2,4]triazolo[4,3-a]quinaz-
olin-5-ol (IIIb). A mixture of 1 g (2.6 mmol) of ester I
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 48 No. 4 2012